Abstract
Pulmonary arterial hypertension (PAH), documented in a significant portion of hypertrophic cardiomyopathy (HCM) patients, has been shown to adversely impact prognosis. In most HCM patients congestive symptoms are consistently elicited by exercise, thus suggesting the need for a provocative test to assess cardiac hemodynamics during effort. Combining cardiopulmonary exercise test (CPET) with echocardiography, we aimed to evaluate the presence of exercise induced pulmonary arterial hypertension (EiPAH), its role in functional limitation and its prognostic significance in a cohort of patients with obstructive and non-obstructive HCM. Study population included 182 HCM patients evaluated combining CPET and stress echocardiography. Left-ventricular outflow tract (LVOT) velocities, trans-tricuspid gradient, and cardiopulmonary variables were continuously measured. Thirty-seven patients (20%) developed EiPAH, defined as systolic pulmonary arterial pressure (sPAP) > 40 mmHg during exercise. EiPAH was associated with lower exercise performance, larger left atrial volumes, higher LVOT gradient and higher VE/VCO2 slope. At multivariable analysis baseline sPAP (p < 0.0001) and baseline LVOT obstruction (p = 0.028) were significantly associated with EiPAH. Kaplan–Meier curve analysis showed EiPAH was a significant predictor of HCM-related morbidity (Hazard Ratio 6.21, 95% CI 1.47–26.19; p = 0.05; 4.21, 95% CI 1.94–9.12; p < 0.001 for the primary and the secondary endpoint respectively). EiPAH was present in about one fifth of HCM patients without evidence of elevated pulmonary pressures at rest and was associated with adverse clinical outcome. Diagnosing EiPAH by exercise echocardiography/CPET may help physicians to detect early stage of PAH thus allowing a closer clinical monitoring and individualized therapies.
Similar content being viewed by others
References
Ommen SR, Mital S, Burke MA et al (2021) 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Thorac Cardiovasc Surg 162:e23–e106
Musumeci MB, Mastromarino V, Casenghi M et al (2017) Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy. Int J Cardiol 248:326–332
Ong KC, Geske JB, Hebl VB et al (2016) Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 17:604–610
Geske JB, Konecny T, Ommen SR et al (2014) Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy. Eur Heart J 35:2032–2039
Finocchiaro G, Knowles JW, Pavlovic A et al (2014) Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy. Am J Cardiol 113:361–367
Covella M, Rowin EJ, Hill NS et al (2017) Mechanism of progressive heart failure and significance of pulmonary hypertension in obstructive hypertrophic cardiomyopathy. Circ Heart Fail 10:e003689
Tolle JJ, Waxman AB, Van Horn TL et al (2008) Exercise-induced pulmonary arterial hypertension. Circulation 118:2183–2189
Naeije R, Saggar R, Badesch D et al (2018) Exercise-induced pulmonary hypertension: translating pathophysiological concepts into clinical practice. Chest 154:10–15
Bossone E, Rubenfire M, Bach DS et al (1999) Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. J Am Coll Cardiol 33:1662–1666
Lewis GD, Bossone E, Naeije R et al (2013) Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 128:1470–1479
Voilliot D, Magne J, Dulgheru R et al (2014) Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis. Int J Cardiol 173:373–379
Guazzi M, Naeije R (2017) Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives. J Am Coll Cardiol 69:1718–1734
Hamatani Y, Amaki M, Yonezawa R et al (2019) Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 35:837–844
Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 17:1321–1360
Rigopoulos AG, Panou F, Sakadakis E et al (2020) Cardiopulmonary exercise test parameters at three months after alcohol septal ablation in hypertrophic obstructive cardiomyopathy are associated with late clinical outcome. Heart Lung Circ 29:202–210
Rudski LG, Lai WW, Afilalo J, Hua L et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the american society of echocardiography endorsed by the european association of echocardiography, a registered branch of the european society of cardiology, and the canadian society of echocardiography. J Am Soc Echocardiogr 23:685–713
Gilbert BW, Pollick C, Adelman AG et al (1980) Hypertrophic cardiomyopathy: subclassification by m mode echocardiography. Am J Cardiol 45:861–872
Maron MS, Olivotto I, Zenovich AG et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232–2239
Georgiopoulou VV, Kalogeropoulos AP, Borlaug BA et al (2013) Left ventricular dysfunction with pulmonary hypertension: part 1: epidemiology, pathophysiology, and definitions. Circ Heart Fail 6:344–354
Re F, Zachara E, Avella A et al (2017) Dissecting functional impairment in hypertrophic cardiomyopathy by dynamic assessment of diastolic reserve and outflow obstruction: a combined cardiopulmonary-echocardiographic study. Int J Cardiol 227:743–750
de Castro C, Faria S, Costa HS, Hung J et al (2020) Pulmonary artery systolic pressure response to exercise in patients with rheumatic mitral stenosis: determinants and prognostic value. J Am Soc Echocardiogr 33:550–558
Taylor BJ, Shapiro BP, Johnson BD (2020) Exercise intolerance in heart failure: the important role of pulmonary hypertension. Exp Physiol 105:1997–2003
Magrì D, Santolamazza C (2017) Cardiopulmonary exercise test in hypertrophic cardiomyopathy. Ann Am Thorac Soc 14:S102–S109
Rowin EJ, Maron BJ, Olivotto I et al (2017) Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 10:1374–1386
van Riel AC, Opotowsky AR, Santos M et al (2017) Accuracy of echocardiography to estimate pulmonary artery pressures with exercise: a simultaneous invasive-noninvasive comparison. Circ Cardiovasc Imaging 10:e005711
Funding
The authors have no source of funding to declare.
Author information
Authors and Affiliations
Contributions
FR, MB and IO conceived the idea presented, wrote the manuscript and supervised the work. GH and FM contributed to the acquisition, analysis, and interpretation of data for the work. PB collected figures and tables and performed the literature research. AA and EZ critically revised the manuscript. All authors contributed to the editorial changes in the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose.
Ethical approval
This study had local institutional and ethics committee approval.
Informed consent
All patients provided written informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Re, F., Halasz, G., Moroni, F. et al. Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test—echocardiographic study. Int J Cardiovasc Imaging 38, 2345–2352 (2022). https://doi.org/10.1007/s10554-022-02671-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-022-02671-3